Sofinnova Investments, Inc. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001631134

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q3 2026 · 63 positions · Total reported value $2.21B · Top-10 concentration 65.9% · Updated 2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

Turnover: 67.6% · 18 new · 21 cut · 11 exited

Active Share (vs S&P 500): 98.0% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -11.7% · vs SPY -13.8% · Prev Value $1.88B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +0.9% · vs SPY -1.3% · Latest Value $2.21B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Sofinnova Investments, Inc. disclosed 63 equity positions with a combined reported value of $2.21B. The filing implies a focused portfolio: its ten largest positions account for 65.9% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were NTRA ($640.75M), GMAB ($155.17M), IWM ($138.94M). By sector, the heaviest allocations are Health Care 91.2%, Other 8.8%. Versus the prior quarter, allocation shifted toward Other (+8.8pp) and away from Health Care (-8.8pp).

Versus the prior quarter, Sofinnova Investments, Inc. opened 18 new positions, trimmed 21 and fully exited 11, a turnover rate of 67.6% of positions. The portfolio's overlap with the prior quarter was 61% of names.

The largest new positions opened in Q3 2026 were IWM ($138.94M), AZN ($61.85M), QQQ ($55.48M).

Of the 11 positions fully exited versus the prior quarter, the largest were SUPN ($48.20M), GILD ($43.35M), COGT ($40.06M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • IWM ISHARES TR · $138.94M
  • AZN ASTRAZENECA PLC · $61.85M
  • QQQ INVESCO QQQ TR · $55.48M
  • LLY ELI LILLY & CO · $50.65M
  • NVS NOVARTIS AG · $28.04M
  • ALNY ALNYLAM PHARMACEUTICALS INC · $27.85M
  • IDXX IDEXX LABS INC · $15.22M
  • BIIB BIOGEN INC · $14.23M

Fully Exited (vs previous quarter)

  • SUPN SUPERNUS PHARMACEUTICALS · prev qtr: $48.20M
  • GILD GILEAD SCIENCES INC · prev qtr: $43.35M
  • COGT COGENT BIOSCIENCES INC · prev qtr: $40.06M
  • ALC ALCON AG · prev qtr: $17.17M
  • INSM INSMED INC · prev qtr: $16.89M
  • ISRG INTUITIVE SURGICAL INC · prev qtr: $15.91M
  • GMED GLOBUS MED INC · prev qtr: $15.80M
  • EXEL EXELIXIS INC · prev qtr: $13.83M

Insider Transactions (Form 4)

Latest Sofinnova Investments, Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Sofinnova Investments, Inc., based in Menlo Park, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 56 positions worth $1.88B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: MENLO PARK, CA, United States
  • SEC registration: 801-110134 (status: Approved), registered 2017-03-22
  • Regulatory AUM (Form ADV): $5.37B as of 2026-03-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 7 private funds, of which 3 hedge funds
  • Website: sofinnova.com

Portfolio Structure

  • 56 positions · $1.88B reported value (Q2 2026)
  • Top 10 holdings = 59.2% of reported value
  • Largest position: NTRA (NATERA INC) at 22.4%
  • Average position size: $33.52M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 13 new, 14 added, 16 reduced, 26 exited
  • 13 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 91.2%
Other 8.8%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.55M $640.75M 28.95%
28.95%
Hold
2 4.35M $155.17M 7.01%
7.01%
Add
3 500.00K $138.94M 6.28%
6.28%
New
4 422.38K $97.79M 4.42%
4.42%
Add
5 2.79M $90.22M 4.08%
4.08%
Hold
6 445.91K $82.22M 3.71%
3.71%
Add
7 3.56M $71.90M 3.25%
3.25%
Hold
8 1.90M $63.99M 2.89%
2.89%
Hold
9 383.05K $61.85M 2.79%
2.79%
New
10 75.00K $55.48M 2.51%
2.51%
New
11 1.70M $51.38M 2.32%
2.32%
Hold
12 534.54K $50.90M 2.30%
2.30%
Add
13 43.78K $50.65M 2.29%
2.29%
New
14 2.51M $40.45M 1.83%
1.83%
Add
15 391.62K $39.19M 1.77%
1.77%
Add
16 946.34K $36.36M 1.64%
1.64%
Add
17 1.63M $35.01M 1.58%
1.58%
Reduce
18 3.59M $31.48M 1.42%
1.42%
Reduce
19 196.70K $28.04M 1.27%
1.27%
New
20 112.88K $27.85M 1.26%
1.26%
New
21 1.75M $26.36M 1.19%
1.19%
Add
22 432.69K $25.96M 1.17%
1.17%
Add
23 329.97K $20.59M 0.93%
0.93%
Reduce
24 207.00K $20.46M 0.92%
0.92%
Add
25 36.49K $19.77M 0.89%
0.89%
Reduce
26 621.69K $19.72M 0.89%
0.89%
Reduce
27 144.05K $17.46M 0.79%
0.79%
Reduce
28 330.40K $16.61M 0.75%
0.75%
Reduce
29 2.29M $16.26M 0.73%
0.73%
Hold
30 626.18K $16.17M 0.73%
0.73%
Reduce
31 29.14K $15.22M 0.69%
0.69%
New
32 1.14M $14.39M 0.65%
0.65%
Add
33 63.00K $14.23M 0.64%
0.64%
New
34 383.59K $13.59M 0.61%
0.61%
Reduce
35 200.00K $13.09M 0.59%
0.59%
Add
36 339.02K $12.90M 0.58%
0.58%
Add
37 523.67K $12.42M 0.56%
0.56%
Hold
38 300.00K $12.18M 0.55%
0.55%
Reduce
39 677.04K $9.93M 0.45%
0.45%
New
40 150.00K $9.08M 0.41%
0.41%
Reduce
41 110.11K $8.66M 0.39%
0.39%
New
42 149.20K $3.17M 0.14%
0.14%
New
43 119.15K $2.88M 0.13%
0.13%
New
44 555.30K $2.35M 0.11%
0.11%
New
45 211.80K $2.31M 0.10%
0.10%
New
46 356.22K $1.84M 0.08%
0.08%
Reduce
47 46.22K $1.81M 0.08%
0.08%
Reduce
48 19.45K $1.66M 0.07%
0.07%
Reduce
49 162.38K $1.60M 0.07%
0.07%
Reduce
50 43.22K $1.54M 0.07%
0.07%
New

FAQ

What did Sofinnova Investments, Inc. buy in 2026-Q3?

In its 2026-Q3 13F filing, Sofinnova Investments, Inc. reported 63 equity positions worth $2.21B in aggregate; its largest disclosed positions were NTRA ($640.75M), GMAB ($155.17M), IWM ($138.94M).

How large is Sofinnova Investments, Inc.'s portfolio?

Sofinnova Investments, Inc. reported $2.21B of long equity holdings across 63 positions as of 2026-Q3. Top-10 holdings account for 65.9% of reported value.

What is Sofinnova Investments, Inc.'s investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/sofinnova-investments/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →